Bristlecone Advisors, LLC Eli Lilly & CO Transaction History

Bristlecone Advisors, LLC

$1.24 Billion
Q3 2024

A detailed history of Bristlecone Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 2,232 shares of LLY stock, worth $1.67 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,232

Previous 2,067 7.98%

Holding current value

$1.67 Million

Previous $1.87 Million 5.67%

% of portfolio

0.16%

Previous 0.16%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $127,403 - $158,403	165 Added 7.98%	2,232 $1.98 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $7,248 - $9,090	10 Added 0.49%	2,067 $1.87 Million
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $4,737 - $6,338	8 Added 0.39%	2,057 $1.6 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $31,511 - $37,147	60 Added 3.02%	2,049 $1.19 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $10,171 - $13,600	29 Added 1.48%	1,989 $932,000
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $223,342 - $262,305	-719 Reduced 26.84%	1,960 $673,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $9,646 - $11,240	-30 Reduced 1.11%	2,679 $980,000
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.04%	2,709 $876,000
Q2 2022 Jul 25, 2022	BUY	$278.73 - $327.27 $264,514 - $310,579	949 Added 53.95%	2,708 $878,000
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $8,448 - $10,499	-36 Reduced 2.01%	1,759 $504,000
Q4 2021 Jan 19, 2022	SELL	$224.85 - $279.04 $295,452 - $366,658	-1,314 Reduced 42.26%	1,795 $496,000
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $19,860 - $25,689	110 Added 3.67%	3,109 $714,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $30,234 - $39,140	-184 Reduced 5.78%	2,999 $560,000
Q4 2020 Jan 25, 2021	BUY	$130.46 - $172.63 $1,695 - $2,244	13 Added 0.41%	3,183 $537,000
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $6,433 - $7,441	44 Added 1.41%	3,170 $469,000
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $24,964 - $30,044	-183 Reduced 5.53%	3,126 $513,000
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $236,790 - $293,079	-1,989 Reduced 37.54%	3,309 $459,000
Q4 2019 Jan 21, 2020	BUY	$106.92 - $132.43 $242,494 - $300,351	2,268 Added 74.85%	5,298 $696,000
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $243,267 - $264,612	-2,278 Reduced 42.92%	3,030 $339,000
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $588,073 - $686,430	5,308 New	5,308 $588,000
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $476,406 - $560,765	-4,280 Closed	0 $0
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $5,189 - $5,813	-49 Reduced 1.13%	4,280 $495,000
Q3 2018 Oct 22, 2018	BUY	$85.86 - $107.31 $371,687 - $464,544	4,329 New	4,329 $465,000
Q1 2018 Apr 24, 2018	SELL	$74.21 - $87.6 $352,423 - $416,012	-4,749 Closed	0 $0
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $81 - $87	-1 Reduced 0.02%	4,749 $401,000
Q3 2017 Oct 20, 2017	BUY	$77.07 - $85.54 $366,082 - $406,315	4,750	4,750 $406,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Eli Lilly & CO Transaction History